echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Eighteen injections and one inhaler were newly announced.

    Eighteen injections and one inhaler were newly announced.

    • Last Update: 2020-08-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network August 7th, August 5, CDE released the "Chemical Generic Reference PreparationS" directory (32batch) published, involving a total of 65 varieties (in terms of drug names), of which 18 for injections, 1 for inhalation agents.
    Minet data show that three injections in 2019 In China's public medical institutions terminal sales of more than 2 billion yuan.
    in cDE's latest list of reference preparations, covering a number of heavy injection stakes, including injection of volicazole, injection with amoxicillin sodium kravicorate potassium, injection of titacycline, etc., in 2019 China's urban public hospitals, county-level public hospitals, urban community centers and township health hospitals (referred to as China's public medical institutions) terminal sales of more than 2 billion yuan.
    Figure 1: Injection with Volikangaconsistency consistency evaluation declaration data show that the injection of Volikangazole has not yet been evaluated by enterprises, 6 enterprises have laid out the product consistency evaluation, including Qilu, Yangzijiang, Hainan Bent and so on.
    six enterprises are reported to the new classification, approved production will be regarded as through the consistency evaluation.
    Figure 2: Injection with the use of dicycline consistency evaluation declaration of injection with dicyclinine has not yet been evaluated by enterprises, 6 enterprises have laid out the product consistency evaluation, including Osaikang, Zhengda Qing, Howson and so on.
    Nanjing Jianyou Biochemical reported the new classification, the remaining 5 enterprises have submitted a consistency evaluation supplementary application.
    pro-chloromione inhalation aerosol is the only inhaler in this list, and the product can be used to relieve asthma symptoms and allergic rhinitis by means of aerosol inhalation.
    no domestic product stakes, four Trump-Trump Pharmaceuticals exclusive to copy three categories of declaration clinical, and in October 2017 approved clinical.
    table: chemical generic reference preparation catalog (thirty-second batch) (draft for comments) Source: Minnet database, CDE Note: data statistics as of August 6, if there are omissions, welcome to correct!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.